Advisory Council on the Misuse of Drugs

Latest documents

Get updates to this list email feed

Copy and paste this URL in to your feed reader

1. Advice on scheduling of cannabis-derived medicinal products

   • Published 19 July 2018
   • Correspondence
   • ACMD

2. ACMD members' register of interests

   • Updated 16 July 2018
   • Corporate report
   • ACMD

3. Medicinal cannabis review part 2 commissioned

   • Published 3 July 2018
   • News story
   • Home Office and ACMD

4. Commission to the ACMD: scheduling under the Misuse of Drugs Regulations 2001

   • Published 3 July 2018
   • Guidance
   • Home Office and ACMD

5. Drug-related harms in homeless populations: public evidence gathering day

   • Published 14 June 2018
   • News story
   • ACMD

6. Legitimate use of controlled drugs: research and healthcare

   • Updated 24 May 2018
   • Correspondence
   • ACMD

7. Custody-community transitions: public evidence gathering day

   • Published 8 May 2018
   • News story
   • ACMD

8. Letter requesting evidence: custody-community transitions

   • Published 8 May 2018
   • Correspondence
   • ACMD

9. Advice on amending the Misuse of Drugs (Safe Custody) Regulations 1973

   • Published 2 May 2018
   • Correspondence
   • ACMD

10. Prescribing of controlled drugs by therapeutic radiographers: further advice

    • Updated 2 May 2018
    • Correspondence
    • ACMD

11. Further new member appointed to the ACMD

    • Published 25 April 2018
    • News story
    • ACMD

12. ACMD work programme for 2017 to 2019

    • Published 28 March 2018
    • Correspondence
    • ACMD

13. Eight new members appointed to the ACMD

    • Published 12 February 2018
    • News story
    • ACMD

14. ACMD letter to the Home Secretary: invitation to the drug strategy board

    • Published 4 December 2017
    • Correspondence
    • ACMD

15. ACMD warns ministers of falling local funding for drug treatment services

    • Published 6 September 2017
    • News story
    • ACMD

16. Commissioning impact on drug treatment

    • Published 6 September 2017
    • Corporate report
    • ACMD

17. Image and Performance Enhancing Drugs: public evidence gathering day

    • Published 16 August 2017
    • News story
    • ACMD

18. Home Office Science non-departmental public bodies (NDPBs): triennial review

    • Published 20 July 2017
    • Corporate report
    • Home Office, ACMD, NDNAD, ASC and Biometrics and Forensics Ethics Group

19. Psychoactive Substances Bill: evaluation review

    • Published 14 July 2017
    • Corporate report
    • ACMD

20. Drug strategy 2016: development review

    • Published 14 July 2017
    • Corporate report
    • ACMD

21. Methiopropamine: a review of the evidence of use and harm

    • Published 16 June 2017
    • Corporate report
    • ACMD

22. Now recruiting: Advisory Council on the Misuse of Drugs members

    • Published 3 April 2017
    • News story
    • ACMD

23. Methylphenidate-based novel psychoactive substances: temporary class drug order recommendations

    • Updated 23 March 2017
    • Policy paper
    • ACMD

24. Further advice on U-47,700, etizolam and other designer benzodiazepines

    • Updated 10 March 2017
    • Correspondence
    • Home Office and ACMD

25. Advice on U-47,700, etizolam and other designer benzodiazepines

    • Updated 21 December 2016
    • Correspondence
    • ACMD

26. Letter from Sarah Newton: U-47,700 and designer benzodiazepines

    • Published 21 December 2016
    • Correspondence
    • ACMD

27. Misuse of Drugs Regulations 2001: impact on research

    • Published 16 December 2016
    • Correspondence
    • ACMD

28. Plant cannabinoids: ACMD report

    • Published 16 December 2016
    • Policy paper
    • ACMD

29. Medicines supplementing use of other illicit drugs, says ACMD

    • Published 15 December 2016
    • Press release
    • ACMD

30. Diversion & illicit supply of medicines

    • Published 15 December 2016
    • Policy paper
    • ACMD

31. New chair of Advisory Council on the Misuse of Drugs

    • Published 14 December 2016
    • Press release
    • Home Office and ACMD

32. ACMD tells ministers drug-related deaths will continue to rise if treatment programmes are not maintained

    • Published 12 December 2016
    • Press release
    • ACMD

33. Reducing opioid-related deaths in the UK

    • Published 12 December 2016
    • Independent report
    • ACMD

34. 'Third generation' synthetic cannabinoids

    • Updated 15 November 2016
    • Correspondence
    • ACMD

35. Temporary class drug order on methiopropamine

    • Published 30 September 2016
    • Correspondence
    • ACMD

36. Problems for Ageing Drug Users Working Group: public meeting invitation

    • Published 9 September 2016
    • Promotional material
    • ACMD

37. Independent prescribing of controlled drugs by therapeutic radiographers

    • Published 5 September 2016
    • Correspondence
    • ACMD

38. Advisory Council on the Misuse of Drugs recruiting new chair

    • Published 24 June 2016
    • News story
    • ACMD

39. ACMD work programme for 2016

    • Published 27 April 2016
    • Correspondence
    • ACMD

40. ACMD review of alkyl nitrites (poppers)

    • Published 16 March 2016
    • Correspondence
    • ACMD